Evidence map›Paper›PMID 40745144›Full record

ArticleAdvances in experimental medicine and biology2025

Translationally Controlled Tumor Protein (TCTP) and Growth Regulation in the Drosophila Model.

Kwang-Wook Choi, Sung-Tae Hong

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kwang-Wook ChoiDepartment of Biological Sciences, Korea Advanced Institute of Science & Technology, Daejeon, Republic of Korea. kchoi100@kaist.ac.kr.
Sung-Tae HongDepartment of Anatomy & Cell Biology, Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. mogwai@cnu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reprogramming tumor cells to a normal state is a central issue in cancer biology. Human translationally controlled tumor protein (TCTP) has emerged as a major player in tumor reversion. However, genetic networks linked to the family of TCTP proteins are complex, and the roles of TCTP in tumor formation and reversion are only partially understood. Genetic analysis in model organisms can provide clues to the biological functions of TCTP in vivo as well as deliver insights into its roles in normal and cancer cells. Studies in the Drosophila model have revealed a wide range of Tctp functions regulating tissue growth, cell death, genome stability, and chromatin organization. Silencing of Tctp suppresses tumorous growth in fly organs, consistent with the human TCTP role in tumor reversion. In this chapter, we focus on the genetic and molecular interactions of Tctp with specific partners involved in growth signaling, DNA repair, and epigenetic regulation in Drosophila. These studies highlight Drosophila as an efficient animal model for studying TCTP functions in growth control and tumor reversion.

Indexed as

Biomarkers, TumorDrosophila melanogasterDrosophila ProteinsNeoplasmsAnimalsCell ProliferationDisease Models, AnimalDNA RepairEpigenesis, GeneticHumansSignal TransductionTumor Protein, Translationally-Controlled 1Biomarkers, TumorDrosophila ProteinsTPT1 protein, humanTumor Protein, Translationally-Controlled 1CancerDrosophilaGenetic modelGrowth controlSignalingTctpTumor reversion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.